Nicolet Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,846
Closed -$355K 216
2020
Q1
$355K Buy
+9,846
New +$420K 0.06% 126

Other funds holding XPH

Nicolet Advisory Services's XPH Position: Q2 2020 in Review

Nicolet Advisory Services sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2020, closing a stake of 9,846 shares — an estimated $355K sold.

Nicolet Advisory Services first reported a position in XPH in Q1 2020 and held it in 1 quarter. The position peaked at $355K in Q1 2020. 73 funds tracked by Wall St. Rank hold XPH as of Q2 2020.

  • Nicolet Advisory Services reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
  • Nicolet Advisory Services sold 9,846 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2020, an estimated $355K.
  • Nicolet Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2020 and held it in 1 quarter.
  • Nicolet Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $355K in Q1 2020.
  • 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2020.

Based on Nicolet Advisory Services's 13F filing for Q2 2020, filed 14 Aug 2020.